Insulet to Present at Upcoming Investor Conferences

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) will present at two major investor conferences: the Raymond James 44th Annual Institutional Investors Conference on March 7, 2023, in Orlando, FL, at 9:15 a.m. ET, and the Cowen 43rd Annual Health Care Conference on March 8, 2023, in Boston, MA, at 10:30 a.m. ET. Interested investors can listen to live audio webcasts at investors.insulet.com/events. The company is a leader in tubeless insulin pump technology with its Omnipod brand, offering innovative products like the Omnipod 5 Automated Insulin Delivery System, simplifying insulin delivery for diabetes management.

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced that management will present at two upcoming investor conferences:

• The Raymond James & Associates 44^th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 7, 2023 at 9:15 a.m. (Eastern Time)
• The Cowen 43^rd Annual Health Care Conference in Boston, MA on Wednesday, March 8, 2023 at 10:30 a.m. (Eastern Time).

To listen to the live audio webcasts of the presentations, please visit investors.insulet.com/events. Replays of the webcasts will also be available following the events.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod^® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.

©2023 Insulet Corporation. Omnipod and Omnipod 5 are registered trademarks of Insulet Corporation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230214005002/en/

Investor Relations:

Deborah R. Gordon

Vice President, Investor Relations

(978) 600-7717

dgordon@insulet.com

Media:

Angela Geryak Wiczek

Senior Director, Corporate Communications

(978) 932-0611

awiczek@insulet.com

Source: Insulet Corporation

FAQ

When will Insulet Corporation present at the Raymond James Conference for PODD?

Insulet Corporation will present at the Raymond James 44th Annual Institutional Investors Conference on March 7, 2023, at 9:15 a.m. ET.

What is the date and time for Insulet Corporation's presentation at the Cowen Health Care Conference?

The Cowen 43rd Annual Health Care Conference presentation will take place on March 8, 2023, at 10:30 a.m. ET.

Where can I listen to the Insulet Corporation presentations for PODD?

You can listen to the live audio webcasts of Insulet Corporation's presentations at investors.insulet.com/events.

What products does Insulet Corporation focus on for diabetes management?

Insulet Corporation focuses on tubeless insulin delivery systems, notably the Omnipod product line, including the Omnipod 5 Automated Insulin Delivery System.

What unique features does the Omnipod 5 system offer?

The Omnipod 5 system provides non-stop insulin delivery, integrates with continuous glucose monitoring, and is controlled via a smartphone, eliminating the need for needle handling.